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Abstract.  Myo2 protein (Myo2p), an unconventional 
myosin in the budding yeast Saccharomyces cerevisiae, 
has been implicated in polarized growth and secretion 
by studies of the temperature-sensitive myo2-66 mu- 
tant.  Overexpression of Smylp, which by sequence is a 
kinesin-related protein, can partially compensate for 
defects in the myo2 mutant (Lillie, S. H., and S.  S. 
Brown.  1992. Nature (Lond.). 356:358-361).  We have 
now immunolocalized Smylp and Myo2p. Both are 
concentrated in regions of active growth, as caps at in- 
cipient bud sites and on small buds, at the mother-bud 
neck just before cell separation, and in mating cells 
as caps on shmoo tips and at the fusion bridge of 
zygotes. Double labeling of cells with either Myo2p or 
Smylp antibody plus phalloidin was used to compare 
the localization of Smylp and Myo2p to actin, and by 
extrapolation,  to each other.  These studies confirmed 
that Myo2p and Smylp colocalize, and are concen- 
trated in the same general regions of the cell as actin 
spots.  However, neither colocalizes with actin.  We 
noted a correlation in the behavior of Myo2p, Smylp, 
and actin, but not microtubules, under a number of 
circumstances.  In cdc4 and cdcll mutants,  which 
produce multiple buds, Myo2p and Smylp caps were 
found only in the subset of buds that had accumula- 
tions of actin.  Mutations in actin or secretory genes 
perturb actin,  Smylp and Myo2p localization.  The 
rearrangements  of Myo2p and Smylp correlate tem- 
porally with those of actin spots during the cell cycle, 
and upon temperature and osmotic shift.  In contrast, 
microtubules are not grossly affected by these pertur- 
bations.  Although wild-type Myo2p localization does 
not require Smylp, Myo2p staining is brighter when 
SMY1 is overexpressed. The myo2 mutant,  when 
shifted to restrictive temperature,  shows a permanent 
loss in Myo2p localization and actin polarization,  both 
of which can be restored by SMY1 overexpression. 
However, the lethality of MY02 deletion is not over- 
come by SMY1 overexpression. We noted that the 
myo2 mutant can recover from osmotic shift (unlike 
actin mutants;  Novick, P., and D.  Botstein.  1985. 
Cell. 40:405--416).  We have also determined that the 
myo2-66 allele encodes a Lys instead of a Glu at posi- 
tion 511, which lies at an actin-binding  face in the 
motor domain. 
M  vo2 protein (Myo2p) is an unconventional  myosin 
in yeast (Saccharomyces cerevisiae), which has 
been classified as a class V myosin on the basis of 
the sequence of the putative motor domain (Cheney et al., 
1993).  Although  Myo2p has not yet been tested for actin- 
based motor activity,  such activity has been demonstrated 
for  a  chicken  class  V  myosin  (Espindola  et  al.,  1992). 
Studies  of the temperature-sensitive  myo2-66 mutant have 
implicated  Myo2p in  polarized  growth  (Johnston  et  al., 
1991). Yeast grow by budding,  a process in which virtually 
all growth is directed to the bud. This process is disturbed 
in the myo2 mutant;  cells at restrictive temperature continue 
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to increase in mass at a normal rate, but fail to produce buds, 
giving'rise to a population of abnormally large round cells. 
In addition, there is a class of abnormally small cells derived 
from buds that ceased growth upon temperature shift and yet 
successfully completed  cytokinesis and  septation.  Chitin 
deposition, normally restricted to the mother-bud neck, also 
becomes delocalized.  Secretion continues, although the con- 
centration  of cytoplasmic vesicles increases.  Actin loses its 
normal polarized  localization,  and,  in addition,  abnormal 
actin "bars" are formed. Other aspects of cell structure and 
function  appear relatively  normal,  including  nuclear divi- 
sion,  and RNA and protein synthesis. 
Actin has also been implicated  in polarized secretion,  not 
only by the phenotype of actin mutants (Novick and Botstein, 
1985), which is similar to that of the myo2 mutant, but also 
by the changing  localization  of actin  during  the cell cycle 
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Filamentous actin is found in both cortical spots and cables 
in wild-type cells. The actin cables are oriented roughly low 
gitudinally  in the mother cell, and extend into the bud. A 
cluster of actin spots forms at the incipient bud site, and spots 
are almost entirely restricted to the growing bud. This polar- 
ity is lost late in the cell cycle, when spots redistribute  to the 
mother cell as well as the large bud. Just before cytokinesis, 
actin spots cluster at the mother-bud neck, where a cell-wall 
septum is being laid  down.  Taken together,  available  evi- 
dence suggests that Myo2p is involved in polarized growth 
by virtue of its interaction  with actin. 
To learn more about the role of Myo2p, we searched for 
multicopy suppressors (heterologous genes that, when over- 
expressed,  can  correct the temperature  sensitivity  of the 
myo2 mutant).  This  search has yielded two genes so far, 
SMYI and SMY2 (_suppressors of myosin; Lillie and Brown, 
1992). We have found that SMY2 (accession #M90654) en- 
codes a novel protein and is not an essential gene.  Interest- 
ingly, overexpression  of SMY2 can also suppress mutations 
in several other apparently unrelated  genes (e.g., sec22 and 
bed, Susan Ferro-Novick, personal communication; secl6-3, 
Neil Green, personal communication;  sptl5, David Pooh and 
Tony Well,  personal communication). 
Surprisingly,  the sequence of SMY1 indicates  that Smylp 
is a member of the kinesin superfamily  (Lillie and Brown, 
1992).  Although  deletion of SMY/has no obvious pheno- 
typic effect in wild-type cells, it is lethal in the myo2 mutant 
(Lillie and Brown, 1992). If Smylp is really a microtubule- 
based motor protein, as its sequence suggests, it is unclear 
how it would compensate for the myo2 defect.  Cytoplasmic 
microtubules are in a position to play a role in polarized 
growth, in that they emanate from the spindle pole body (the 
equivalent of the centriole), and become oriented toward and 
extend  into the bud (Adams  and Pringle,  1984;  Kilmartin 
and Adams,  1984). However, unlike actin,  microtubules do 
not appear to be required for polarized secretion.  That is, in 
cells lacking  microtubules,  buds both form and grow nor- 
mally; such cells instead show defects in nuclear positioning 
and mitosis (Jacobs et al.,  1988; Huffaker et al.,  1988). 
To further explore the function  of Myo2p and the nature 
of its  interaction  with  Smylp,  we have  immunolocalized 
Myo2p and Smylp. We compare their localizations to that of 
actin and microtubules during the cell cycle and during per- 
turbation by temperature or osmotic shift. We examine how 
Myo2p and  Smylp  localizations  are  affected  in  mutants 
defective  in  actin,  Myo2p, or secretory proteins,  and by 
SMY1 overexpression.  In addition,  we report the sequencing 
of the myo2-66 mutation. 
Materials and Methods 
Reagents 
Yeast lyric enzyme was obtained from ICN Biochemicals (Cleveland, OH). 
CHAPS was  obtained from Polysciences  Inc.  (Warrington,  PA).  Rabbit 
anti-goat and goat anti-rabbit IgG were from Jackson hnmuno Research 
Laboratories, Inc. (West Grove,  PA). FITC-conjngated  goat anti-rat IgG 
(affinity  purified),  and  F1TC-conjngated  goat  anti-rabbit IgG  (affinity 
purified) were from Sigma Chem. Co. (St. Louis, MO). YOL1/34 anti-yeast 
tubulin monoclonal antibody was from Accurate Chemical and Scientific 
Corp.  (Westbury,  NY).  Rhodamine-conjugated  phalioidln, as a  3.3-~M 
stock in methanol, was from Molecular Probes Inc. (Eugene,  OR). Horse- 
radish peroxidase-conjugated  goat anti-rabbit IgG (affinity purified)  was 
from Bio-Rad Labs.  (Richmond, CA). The ECL kit was from Amersham 
Corp. (Arlington Heights,  IL). 
Yeast Strains and Media 
All yeast strains used are listed in "Fable I. Liquid media used were rich 
medium YM-P (Lillie and Pringle, 1980) and synthetic complete medium 
SC lacking the appropriate supplement to select for plasmid (Sherman et 
al.,  1986).  Standard (Sherman ct al.,  1986) solid media were used, rich 
medium YPD and minimal medium SD with the required nutritional sup- 
plements.  For all media,  glucose was  autoclaved  separately  and added 
to 2%. 
DNA Manipulations,  Yeast Genetic Techniques, 
and Plasmids 
Standard procedures were used for DNA manipulations and Escherichia 
coli transformation (Sambrook et al.,  1991), and for yeast transformation 
(by the lithium acetate method) and genetic manipulations (Sherman et ai., 
1986). 
Plasmid pJP10-2B (which we refer to as YCpMYO2) was kindly provided 
by G. Johnston (Johnston et al., 1991). This low-copy-number plasmid con- 
tains the full-length  MY02 gene. The full-length SMY/gene was introduced 
into the high-copy-number vectors YEp351  (2/z LEU2) and YEp352 (2 # 
URA3) (Hill et al.,  1986) as follows: To construct plasmid YEpSMY1-26, 
the ,~4.5-kbp Eco RV SMY/-containing fragment from the genomic library 
clone (Lillie and Brown, 1992) was inserted at the Sma I site of YEp352. 
YEpSMYL38  was  constructed by  inserting the  "~3.5-kbp  Pst I  SMY/- 
containing fragment from YEpSMYI-26  into the Pst I site of YEp351. (One 
end of this insert is derived from vector sequence.) To truncate SMY/, 
YEpSMY1-40 was created by digesting YEpSMY1-26 with Sst I and religat- 
ing to remove the COOH-terminal 79 amino acids of SMY/product. This 
truncated gene encodes the complete head domain and 206 amino acids of 
the tail. 
MY02 Deletion 
Plasmid pAM::TRP1, which contains the MY02 deletion allele (see Fig. 10 
c),  was  constructed by inserting sequentially  the NH2-terminal  MYO2- 
containing fragment, the COOH-terminal MYO2-containing fragment, and 
finally  the  yeast  TRPl  gene  into  the  multiple-cloning-site  region  of 
Bluescript (Stratagene,  LaJolla, CA) vector pSK  + as follows: The ,~l-kbp 
Eco RV-Pvu H fragment from YCpMYO2-10 (derived from YCpMYO2) 
was inserted at the Xba I site in pSK  + after treatment with Klenow frag- 
ment to fill the Xba I ends. (The F.co RV site of this fragment lies in vector 
sequence as indicated in Fig.  I0, a and c and was destroyed  by insertion 
into the filled Xba I site.) Next, the ,'o500-bp Eco RV-Cla I fragment was 
inserted at the Eco RV/CIa I sites of pSK  +. Finally,  the Barn HI-Eco RI 
TRPl-containing  fragment was inserted into the Bean HI/Eco RI sites of 
pSK  + to yield plasmid pAM::TRPI. 
A  trpl/trpl diploid was transformed with the gel-purified  Bgl II-Cla I 
fragment (Fig.  10) from pAM::TRPI to delete the MY02 gene by one-step 
gene replacement (Rothstein,  1991). Two ~II-p  + transformants were picked 
and found to be stably Trp  +. Southern blot analysis of these two diploids 
confirmed that the expected deletion had occurred, and tetrad analysis of 
these strains gave the expected results (Johnston et al.,  1991; see Results). 
Mapping and Sequencing the myo2-66 Mutation 
The mutated region of the MY02 gene was identified by marker-rescue ex- 
periments as follows: The temperature-sensitive myo2 ura3 mutants SLY1 
and SLY33 were transformed at room temperature (RT) 1 with autono- 
mously replicating  YEp or YCp  URA3-hased plasmids containing frag- 
ments of the wild-type MYO2 gene.  Ura  + transformants were plated at 
36°C. If, and only if, the MYO2 fragment included DNA corresponding to 
the mutated region in the chromosome, gene conversion gave rise to papil- 
lae of growth on a background of temperature-sensitive  (non-growing) cells. 
In this way the mutation was found to reside in a 1-kbp Xba I segment (Fig. 
10 e). Conversely, a plasmid that included all of the MYO2 gene except this 
1-kbp Xha I fragment riffled to provide marker rescue. 
To  recover this segment by "gap  repai~  (Rothstein,  1991),  plasmid 
YCpMYO2 was cut with Xba I and religeted to yield YCpMYO242  (Fig. 
10  d),  which  lacks  the  1-kbp  Xba  I  segment.  When  (URA3-based) 
1. Abbreviation  used in this paper:  RT, room temperature (19-22°C). 
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Strain  Relevant genotype*  Source 
SLY1  MATa myo2-66' ura3-52 trpl-Al his6 ade2  This study 
SLY33  MATa myo2-66 ura3-52 1eu2-3,112  This study 
SLY34  MATer myo2-66 ura3-52 leu2-3,112  This study 
SLY54  MATa ura3-52 1eu2-3,I12 trp  l-289 his4  This study 
SLY56  MATa ura3-52 1eu2-3,112 his4  This study 
SLY86  MATa smyl-A2::LEU2  ura3-52 1eu2-3,112 trpl-289 his4  This study 
MATu smyl-A2::LEU2  ura3o52 1eu2-3,112 TRPI  his4 
SLY87  MATa ura3-52 leu2-3,112 trpl-289 his4  This study 
MAT~ ura3-52 1eu2-3,112 TRP1  his4 
SLY88  MATa myo2-66 ura3-52 leu2-3,112 trpl-Al his3 his6  This study 
MAT¢ myo2-66 ura3-52 Ieu2-3,112 TRP1 HIS3 HIS6 
SLY91  MATa myo2-66 1eu2-3,112 his3  This study 
MATer myo2-66 leu2-3,112 HIS3 
SLY107  MATa myo2A::TRP1 trpl-A1  ura3-52 1eu2-3,112  This study 
MATc~ MY02  trp  l-289 ura3-52 leu2-3,112 
SLY175  MATa ura3-52  This study 
SLY176  MATc~ ura3-52  This study 
DBYI999  MATa actl-D ura3-52  D.  Botstein 
DBY2003  MATa ura3-52  D. Botstein 
DBY2018  MATa actl-2 his4-619  D.  Botstein 
(2276  MATa prototrophic  J.  Pringle 
MATa 
JPT194-HO 1  MATa cdcll-6 prototrophic  J.  Pringle 
MAT~ cdcll-6 
314D5  MATa cdc4-1 adel ade2 ural tyrl  J.  Pringle 
MAT¢ cdc4-1 adel ade2 ural tyrl 
NY3  ×  NY411  MATa secl-1 ura3-52 his4  This study 
MATer secl-1  URA3 HIS4 
NY16  x  NY17U  MATa sec6-4 ura3-52 his4  This study 
MATa sec6-4 URA3 HIS4 
NY757  x  NY76011  MATa secT-1 ura3-52 his4  This study 
MATa sec7-1 URA3 HIS4 
* Some sU'ains may carry additional mutations; most or all are $288C derivatives and therefore gal2. 
The myo2-66  allele was obtained from Gerry Johnston in strains GR663-7 and GR663-13, and crossed into our strain background. 
§ Formerly known as actl-3 (Novick et al.,  1989). 
II These diploids were made by mating the indicated haploids, NY3 etc.,  obtained from P. Novick. 
YCpMYO2-12, linearized with Xba I, was introduced into myo2 ura3 yeast, 
some of these plasmid molecules are n~alred from chromosomal informa- 
tion, giving rise to Ura  + transformants. Such gap repair plasmids were re- 
covered from one transformant each of myo2 uroJ mutants SLYI and SLY33 
and were named YCpGapl and YCpGap4,  respectively.  The 1-kbp Xba I 
segment from each, as well as the corresponding wild-type  segment from 
plesmid  YCpMYO2,  were  shuttled  to  Bluescript  sequencing  vectors. 
Single-strand sequence of each Xba I fragment was obtained  by the dideoxy- 
chain termination method (sanger et al., 1977). As our sequencing did not 
extend beyond this Xba I fragment, we cannot rule out the possibility that 
an additional mutation outside of this region was recovered by "chew-back" 
in the gap ~  plasmid. 
Preparation of Total E. coli and Yeast Proteins, 
Gel Eiectrophoresis,  and Protein Blotting 
Total E. coli  proteins were prepcred from cells grown under the appropriate 
inducing conditions (see below) as follows: Cells were collected by centrifu- 
gation and resuspended in SDS-solubilizing  buffer (Laemmli, 1970) plus 
6 M urea, heated 3 rain in a boiling-water bath, and loaded onto gels (see 
below). 
Total yeast proteins were prepared from log-pbase cells growing in the 
appropriate medium following suggestions by D. Drubin (UC Berkeley) as 
follows: Working as quickly  as  possible, cells were collected by centrifuga- 
tion and resuspended by sonication into prewarmed SDS-solubilizin~ buffer 
plus protease inhibitors (Lillie and Brown,  1987). Samples were placed in 
a boiling-water bath for 3 rain, glass beads (0.5 ram) were add, the mix was 
votexed 60 s, and loaded onto standard SDS-polyacrylamide  gels,  which 
were either stained with Coomassie blue or blotted to nitrocellulose as de- 
scribed previously (Liilie and Brown,  1987). Blots were stained with Pon- 
ceau S (Lillie and Brown,  1987) to assess relative amounts of proteins trans- 
ferred. 
Constructions of  Gene Fusions 
The 2.35-kbp Hpa I-Cla I fragment of MYO2 encodes the tail portion of 
Myo2p from amino acid 833 through the end of the coding region (Fig.  10 
b). To create a trpE:MF02 gene fusion, this fragment was inserted into Sma 
I/Cla I  -  cut fusion vector pATH2  (Koerner et al.,  1991). To create a 
lacZ:MY02 gene fusion, the same fragment was inserted into the Hind HI 
site of fusion vector pUR290 (F4ither and Mitiler-Hill, 1983) after treating 
both fragment and vector with Klenow fragment to produce blunt ends. 
The 715-bp Dra I-Sac I fragment of SMY/encodes the tail portion of 
Smylp from amino acid 410 through 647 (this fragment lacks the last 9 
amino acids of Smylp).  TO create trpE:SMYl and lacZ:SMY1 gene fusions, 
the fragment was inserted into the Cla I site of pATH1 (Koerner et al., 1991) 
and the Bem HI site of pUR291  (Rfither and Mfiller-HiU,  1983), respec- 
tively, after treating each vector with Klenow fragment to produce blunt 
ends. 
Preparation of  Antigens and Antibodies 
The lacZ:MY02 and lacZ:SMYl fusion proteins were induced in E.  coil 
strain BMH 71-18 as described by Kim et al. (1991), except that induction 
was at 30oc rather than 37°C. The trpE:MY02 and trpE:SMYI fusion pro- 
teins were induced in E. coil strain RR1 as described by Hearer and Pringie 
(1987), except that induction time ranged from 1 to 4 h. Proteins were sepa- 
rated on gels (see above); gel slices containing fusion protein were excised 
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1987). 
Antibody A~inity Purification and Immunoblots 
Myo2p- and Smylp-specific  antibodies were affinity purified from crude an- 
tisera using nitrocellulose strips containing the heterologous fusion protein 
as affinity matrix (e.g., trpE:MY02 antiserum on lacZ:MY02 affinity ma- 
trix, etc.). In some cases, a second round of affinity purification was per- 
formed; this used the homologous fusion protein as affinity matrix. Affinity 
purifications were carried out as described by Lillie and Brown (1987) and 
Pringle et ai. (1991), except that after elution in low pH buffer, the purified 
antibody was neutralized with an equal volume of I00 mM Tris base con- 
taining 1%  BSA. Affinity-purified Smylp antibody was adsorbed against 
fixed SMY/deletion cells as an additional purification step (Roberts et al., 
1991). However, as this step did not alter the staining pattern of cells, it was 
not included  routinely. 
To assess antibody specificity and the success of affinity purifications, 
blots of  total E. coil or yeast proteins were probed with affinity-purified  anti- 
body and fractions generated during affinity purification as described previ- 
ously (Lillie and Brown, 1987).  For detection of bound antibody, we used 
either 4-chioro-l-naphthol and hydrogen peroxide as described previously 
(Lillie and Brown,  1987),  or ECL staining (performed according to the 
manufacturer's instructions). 
Growth Conditions for Immunofluorescence 
Cells were grown at RT (19-22°C), unless otherwise indicated, in the ap- 
propriate liquid medium with rotary shaking for at least 16 h, subculturing 
if necessary to maintain log phase cells at ~107 cells/ml. Cells were then 
fixed for immunofluorescence (see below) or shifted to experimental condi- 
tions. 
To obtain cells responding to mating pheromone (shmoos) and zygotes, 
haploid strains of opposite mating types (SLY175 and SLY176) were grown 
separately in YM-P at RT to '~107 cells/ml. Five ml of each culture were 
then mixed in a 50-rnl fask and incubated with shaking for 1 h. Shaking 
then was discontinued for the duration of the experiment to allow cells to 
mate, and aliquots were processed for immunofluorescence microscopy at 
intervals over 5  1/2 h.  The expected transient rearrangements of actin, 
Myo2p, and Smylp were observed in response to discontinuation of shaking 
(see Discussion), but the cells had recovered by the time period of interest. 
Many shmoos and zygotes had formed by 3  1/4 h after mixing, while at 4 
1/4-5  1/2 h the majority of zygotes had produced a first bud. 
Temperature-sensitive cdc4, cdcll,  secl, see6, sec7, actl-1, and act1-2 
mutants, and the appropriate parent (control) strains were grown at permis- 
sive temperature (RT for most strains) in YM-P to ~107 cells/nil. (For the 
actl mutants, which are somewhat abnormal even at RT, 18-20°C was used 
as permissive temperature.) To shift cells to restrictive temperature, ali- 
quots were diluted fivefold into prewarmed YM-P at 36°C. 
The myo2 (ura3) mutant plus plasmid, or control vector, was grown at 
<20°C in SC-uracil to select for plasmid. To shift cells to restrictive tem- 
perature, aliquots of the culture were diluted fivefold into prewarmed SC- 
uracil at 30, 32, or 36°C. (Mock-shifted control cultures were diluted into 
medium at ~20°C.) 
To examine the effects of temperature shift itself, wild-type strain SLY87 
was grown in YM-P; strain SLY87 carrying plasmid YEpSMY1-26 or con- 
trol vector was grown in SC-uracil, and SMY/deletion strain, SLY86, was 
grown in SC. Cells were grown to gl07 cells/mi at RT. For each time point 
of the temperature shift, 1 ml was removed rapidly from the RT culture and 
added to 9 ml of medium which was shaking and prewarmed to 36"C (or 
at RT for mock-shift control cultures). 
For osmotic-stress experiments, strains (SLY87,  SLY86,  and  SLY88) 
were grown in YM-P at 20°C to a density of '~5 x  106 cells/ml. Osmolar- 
ity of  the cultures was increased by addition of  0.4 M NaCI (using 5 M NaCI 
stock). A comparable volume of water was added to control cultures. 
Immunofluorescence Microscopy 
For most experiments, cells were fixed for immunofluorescence  microscopy 
by adding 37% formaldehyde directly to the shaking culture to give a final 
concentration of 3.7 % and shaking was continued for the duration of fixation 
(1-1 1/2 h). For some experiments with several time points, aliquots of cul- 
ture were pipetted quickly to formaldehyde-containing tubes which were 
placed on a roller drum during fixation. We found that this latter procedure 
did not detectably perturb the cellular actin arrangement, a sensitive indica- 
tor of rapid fixation (see Results). Immunofluorescence results were indis- 
tinguishable using cells grown in either rich medium (YM-P) or minimal 
medium (SC), and no differences were noted when using parental (wild- 
type) strains from several different laboratories (Table I). 
For immunofluorescence localization of Myo2p and Smylp, we used 
procedures based on those of Pringle et al.  (1991),  with the following 
modifications: Yeast cells were fixed in 3.7%  formaldehyde for 1-1  1/2 h. 
(Longer fixations [~3 hi gave poor Myo2p staining and eliminated detect- 
able Smylp staining; limited attempts to find an alternative to formaldehyde 
fixation failed.) After washes in 1.2 M sorbitol/phosphate buffer (solution 
A of Pringle et ai.,  1991), cell walls were removed from ,~10  s cells in 1 
ml solution A containing 5 ~1 ~-mercaptoethanol and 30 ~1 of yeast lyric 
enzyme stock (10 mg/ml in solution A). Incubation was for 30 rain at 36°C 
with gentle agitation. For Smylp staining, best results were obtained if 
washed spheroplasts (stored at 4"C in solution A) were used within 12 h. 
Spheroplasts were attached to polylysine-coated mnitiwell slides and in- 
cubated for 5-30 rain in phosphate buffer/BSA (solution F of Pringle et ai., 
1991) before addition of affinity-purified primary antibody or additional 
treatments as appropriate. Solution F was used for all washes and antibody 
dilutions. For Myo2p staining, either of two procedures was used. Cells 
were incubated with primary antibody (at 1:10-1:20 dilution) for 10-12 h 
at RT, or cells were pretreated with methanol at -20°C for 6 rain, followed 
by 30 s in acetone at -20°C, and then incubated with primary antibody for 
2-4 h. For Smylp staining, cells were treated with detergent (either 0.5% 
SDS or 0.5 % CHAPS) for 3-4 min, washed five times, and incubated with 
primary antibody (at 1:5-1:10 dilution) for 4-8 h at RT. After incubation 
with primary antibody, antibody amplification (Roberts et al., 1991), which 
was essential for Smylp and helpful for Myo2p visualization, was accom- 
plished by treatment with goat anti-rabbit IgG (at I ~g/ml) for 1 h, and then 
rabbit anti-goat IgG (at 1 f,g/ml) for 1 h, and finally FITC-conjngated goat 
anti-rabbit IgG (at 1:80 dilution) for 1-2 h. Wells were washed four times 
between secondary antibodies. 
Microtubules were visualized using the anti-yeast tubulin monocional an- 
tibody YOLI/34  (Kilmartin and Adams,  1984)  and actin was visualized 
using anti-yeast polyclonal antibodies as described previously (Haarer et 
al.,  1990). 
For double labeling of  Myo2p or Smylp and actin, rhodamine-conjngated 
phalloidin was used to visualize actin as described by Adams and Pringle 
(1991).  As treatment of cells with methanol/acetone or SDS destroys the 
ability of phalloidin to interact with actin, we used the treatments described 
above that avoided those reagents. 
Nuclei were stained by adding 4',6-diamidino-2-phenyl-indole  (DAPI) to 
the mounting medium (Kilmartin and Adams,  1984). 
Stained  cells  were viewed with an Orthoplan fluorescence microscope 
and photographed using TMAX 400 film (EasUnan Kodak Co., Rochester, 
NY). Negatives were printed using different exposure times to optimize de- 
tail, except as noted. 
Quantitation of  Filamentous Actin upon 
Temperature Shift 
Quantitation of  filamentous actin and fluorescence microscopy were carried 
out on temperature-shifted cells, using rhodamine-phalloidin. Cells ((2276) 
were grown in YM-P at RT to a density of '~107 cells/ml. For each time 
point, I ml was removed rapidly  from the RT culture  and added to  9 ml 
of  YM-P medium which  was  shaking  and  p~owarmed  to  37°C (or  at  RT for 
mock-shift control cultures). One ml 37% fommldehyde, also p~, 
was added while  the  above culture  was still  shaking.  After I/2  h, cultures 
were  removed  from  the  shaker  and  fixation  continued  overnight  at  RT. The 
cells  were collected  by centrifugation,  incubated  in 100/~l  of 0.33/~M 
rhodamine-phalloidin,  0.2% Triton  X-100 in  PBS for I/2  h in  the  dark on 
a roller  drum at  RT, and  then  washed twice  with  PBS. A 1/20  volume was 
reserved for fluorescence microscopy, and the rest of the cells were col- 
lected by centrifugation and incubated for 1 I/2 h in 700 ~1 methanol on 
a roller drum in the dark. Extracted fluor was qnantitated by fluorimetry 
(Howard and Oresajo,  1985).  We confirmed by diluting aliquots of fixed 
cells two- or fourfold before phalloidin staining that fluorescence was linear 
in this range. Cells before temperature shift bound ~7% of the input phal- 
loidin. 
Results 
Myo2p Antibody Specificity 
Members of the myosin superfamily are similar to one an- 
other  in  their  motor  domains,  but  have  divergent  tails. 
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of Myo2p, to reduce the possibility of crossreactivity with 
other yeast myosins. As antigens we used fusion proteins that 
included amino acids 833-1574  (i.e.,  the COOH-terminal 
half) of Myo2p. Both trpE:MY02 and IacZ:MY02 gene fu- 
sions were made, so that antibody raised against one fusion 
protein could be affinity  purified against the heterologous fu- 
sion protein (Haarer and Pringle,  1987).  Affinity-purified 
antibodies were tested for specificity on blots of total yeast 
protein (Fig.  1 a).  Whereas the crude antiserum (lane/) 
stained multiple bands,  affinity-purified antibody (lane 2) 
stained only one major band,  at the expected molecular 
weight. (We sometimes saw minor bands; as these varied 
from sample to sample, we believe they are due to proteoly- 
sis.) A  second round of affinity purification demonstrated 
that all of the antibody affinity purified against the heterolo- 
gous fusion protein (lane 2) could be subsequently affinity 
purified against the homologous fusion protein  (compare 
lanes 3 and 4). This confirmed that the antibody specifically 
recognizes the Myo2p portion of the fusion proteins. Thus, 
imrnunoblotting demonstrates  the  efficacy of the  affinity 
purification, and confirms that the staining is not simply 
spillover or contamination from the depleted fraction. Addi- 
tional immunoblotting evidence that the antibodies specifi- 
cally  recognized  Myo2p  include the  following (data  not 
shown):  (a)  Antibody produced against  each  of the  two 
different fusion proteins stained the same molecular weight 
band when affinity-purified antibody but not when depleted 
serum was used. (b) Introduction of MY02 on a high-copy 
number plasmid resulted in a low level of overexpression of 
Myo2p on immunoblots. (We did not expect a high level of 
overexpression, because the plasmid appears to be selected 
against and copy number is most likely reduced in these 
cells; Haarer et al.,  1994).  (c) Introduction of a truncated 
MY02 (see below) results in the appearance of a new band 
of the expected molecular weight on immunoblots. (d) We 
have also confirmed that the stained band corresponds to 
Myo2p, using a strain that carried only HA-tagged Myo2p 
(generously provided by Govindan, B., and E  Novick, Yale 
University). Proteins were separated on a 5 % gel to max- 
imize resolution in the vicinity of Myo2p. When adjacent 
strips of  the immunoblot were treated with anti-HA antibody 
and  the  Myo2p antibody,  a  band  of the  same molecular 
weight was stained. 
Antibody specificity was also examined upon immunofluo- 
rescence labeling of  yeast. We found that affinity-purified  an- 
tibody from both the first and second round of purification 
gave the localization patterns described in the next section, 
whereas neither depleted fraction generated during affinity 
purification gave this localization. Thus, the localization we 
report is specific, and not due to spiUover during affinity 
purification. Similar immunofluorescence results were ob- 
tained with antibody against either of  the two fusion proteins 
described above. Furthermore, the alterations in localization 
we describe below, including fainter staining of the myo2 
mutant at permissive temperature and abolition of localiza- 
tion at restrictive temperature, are consistent with the evi- 
dence that the staining is specific for Myo2p. 
Cells  stained  with the  depleted  fraction from the  first 
round of affinity purification gave a speckled appearance as 
well as a bright overall glow; this staining pattern was much 
fainter when affinity-purified fractions or the depleted frac- 
Figure 1. Demonstration of antibody specificity on immunoblots. 
(a) Anti-Myo2p antibody labeling of a blot of total yeast protein 
(strain SLY87). Crude serum against trpE:MY02 fusion protein 
(lane 1) was affinity purified against lacZ:MY02 fusion protein. The 
affinity-purified  antibody (lane 2) was taken through a second round 
of affinity purification against trpE:MY02 fusion protein, to gen- 
erate depleted (lane 3) and twice-atfmity-purified  (lane 4) frac- 
tions. (b) Anti-Smylp antibody labeling. Affinity-purified  antibody 
against trpE:SMYI fusion protein was used to label blots of total 
protein from wild-type cells (SLY87) (lane 1 ), or from SMY/dele- 
tion cells (SLY86) either without added plasmid (lane 2), with plas- 
mid encoding full-length SMIq (YEpSMY1-26) (lane 3), or en- 
coding truncated SMY/ (YEpSMY1-40) (lane 4).  Proteins were 
separated on 7% SDS-polyacrylamide  gels and visualized on West- 
era blots with ECL reagent (a) or t~-chloro-naphthol  (b). Molecular 
masses of protein standards are indicated in kDa, and the positions 
of Myo2p (M) and Smylp (S) are labeled. 
tion from the second round of  affinity  purification were used. 
Therefore,  at  least some of this  staining pattern  is  non- 
specific. 
We  have  identified a  second  class  V  myosin in  yeast 
(Myo4p;  Haarer  et ai.,  1994).  Even though the level of 
amino-acid similarity to Myo2p is low in the tail, we looked 
for evidence of antibody crossreactivity. None was found; 
antibodies against Myo2p and Myo4p each label a band of 
different molecular weight on Western blots, with no detect- 
able crossreactivity. Furthermore, immunofiuorescence mi- 
croscopy  showed the  same  Myo2p  staining pattern  in  a 
MY04 deletion strain as in wild-type cells (data not shown). 
Immunolocalization of Myo2p 
In  both  haploid  and  diploid  wild-type  strains  (SLY54, 
SLY56, SLY87), Myo2p was concentrated as a cap at or near 
the membrane on unbudded cells and small buds (Fig. 2, a, 
b, and c). These caps were usually at the tip of the bud, but 
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of Myo2p in wild-type cells. 
Cells  (SLY87) were labeled 
with  anti-Myo2p antibody. 
Shown  is a sequence  of  cells at 
various stages of the cell cy- 
cle: (a) unbudded cells with a 
Myo2p cap,  (b) small-budded 
cells with a Myo2p cap, (c) 
cells with slightly larger buds 
(note that the Myo2p cap can 
be off center, e.g., in the cell 
tO  the  /eft), (d)  mexiium- 
budded cells without a cap, (e) 
large-budded cells without a 
cap  (note that the  bud  may 
have a brighter glow than the 
mother cell, e.g., in the cell to 
the  r/ght),  (f)  large-budded 
cells  with  stainins  at  the 
mother-bud neck, (g) unbud- 
ded cells with a fiat patch of 
Myo2p,  (h)  unbudded cells 
with both a cap and fiat patch 
of  Myo2p staining. Bar, 5/~m. 
were sometimes a little off-center (Fig. 2 c, cell on the/eft). 
Discrete cap staining disappeared as buds enlarged (Fig. 2, 
d and e), although a glow or multiple spots of Myo2p per- 
sisted in some medinm-sized buds  (Fig.  2  e,  cell on the 
right).  Myo2p appeared  at the neck between mother and 
daughter cells (Fig. 2 f) shortly before cytokinesis and cell 
septation (i.e., in cells that had completed nuclear division, 
as judged by DAPI staining). Some unbudded cells had a flat 
patch instead of a  rounded cap of Myo2p (Fig.  2  g).  In 
diploid  strains,  which  display a  bipolar  budding pattern 
(Chant and Pringie, 1991), an occasional unbudded cell had 
both a cap and at the opposite end a flat patch of  Myo2p (Fig. 
2 h). (As expected, this was not observed in haploids, which 
display a  unipolar budding pattern.)  Most likely the cap 
marks the new bud site and the flat patch is a "leftover" from 
the neck staining, marking the site of the previous cell divi- 
sion.  (Further support for this interpretation will be pro- 
vided below.)  The morphological distinction between caps 
and patches presumably reflects the cell shape where the sep- 
rum is laid down between mother and bud at the neck. Cells 
at all stages of the cell cycle also displayed a background 
glow and speckles. This staining was variable, and some or 
all may be nonspecific, as mentioned above. 
It is striking that Myo2p was concentrated at sites of active 
growth in these vegetative yeast cells. We therefore asked if 
Myo2p were also localized to sites of active growth in mating 
cells.  Such cells form projections ("shmoos") which fuse 
with a partner of the opposite mating type. Exponentially 
growing haploid strains (SLYI75  and SLYI76)  were mixed 
to induce shmoo formation and mating. Myo2p was indeed 
localized in caps  at  shmoo tips,  at the  fusion bridge of 
zygotes, and as a pronounced cap on the zygote's first bud, 
all regions of polarized growth. 
Smylp Antibody Specificity 
We have used the same strategy as described for Myo2p anti- 
body to obtain affinity-purified  antibody against the tail por- 
tion of Smylp (amino acids 410-647). Antibodies against ei- 
ther of  the two fusion proteins containing the Smylp tail gave 
the same immunoblotfing and immunofluorescence results. 
As an additional purification step, we sometimes adsorbed 
the affinity-purified  antibody against cells of  a SMY/deletion 
(smylA) strain (SLY86).  However, as this treatment did not 
alter the localization we report, it was not routinely  included. 
Affinity-purified antibody stained a  fuzzy band of the ex- 
pected molecular weight on immunoblots (Fig. 1 b, lane/). 
This band was not seen in a smylA strain (lane 2), and was 
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number plasmid (lane 3). Furthermore, a smylA strain car- 
rying truncated SMY/on a plasmid gave a lower molecular 
weight band of the expected size (lane 4). (The minor bands 
seen in lanes 3 and 4 are presumably proteolytic fragments, 
as they are not seen in lanes 1 and 2.) Thus, it is clear that 
the atfmity-purified antibody specifically recognizes Smylp 
on immunoblots. Results consistent with the immunoblots 
were obtained when these various strains were examined by 
immunofluorescence (see below). 
Immunolocalization of  Smylp 
Strikingly, the localization of Smylp (Fig. 3) was indistin- 
guishable from that of Myo2p in both haploid and diploid 
wild-type cells (SLY54, SLY56, SLY87), although the inten- 
sity of Smylp staining was variable in different experiments. 
Smylp formed caps in unbudded and small-budded cells, 
and, occasionally, staining of the mother-bud neck was de- 
tectable (in the two cells at the bottom of Fig. 3 a). Smylp 
also formed flat patches (distinct from caps) in unbudded 
cells (Fig. 3 b, arrows). In mating cells, Smylp was found 
in the same locations as reported above for Myo2p. In all 
cells stained with Smylp antibody, background glow and 
speckles were also seen. The smylA strain (SLY86) did not 
show staining of caps, necks, or flat patches, and the back- 
ground glow and speckles were greatly reduced as well. 
These observations demonstrate the specificity of the stain- 
ing patterns we see,  including at least some of the back- 
ground  glow  and  speckles.  Cells  overexpressing  SMY/ 
(SLY87  +  YEpSMYI-26) displayed the same Smylp local- 
izations as wild type (Fig.  3 b),  although the intensity of 
staining increased significantly, and therefore the frequency 
of cells with detectable Smylp also increased.  Most cells 
overexpressing Smylp also displayed a big increase in the 
background glow. It appears that cells can localize part of 
the excess Smylp, but that some may remain diffusely dis- 
tributed. 
We have begun to ask what parts of the Smylp molecule 
are required for localization, by examining a smylA strain 
with plasmid-borne truncated SMT/(SLY86 +  YEpSMY1- 
40).  It can be seen in Fig.  1 b  (lane 4) that the truncated 
Smylp  is  (over)expressed,  has  the  expected  molecular 
weight, and is recognized by antibody. However,  the trun- 
cated Smylp did not localize properly. All that was seen by 
immunofluorescence was an increased cytoplasmic glow, as 
compared  to  the smylA  strain carrying a  control vector 
(SLY86  +  YEp352).  As expected, strain SLY86 carrying 
full-length SMY/(YEpSMY1-26) did display normal Smylp 
localization. We conclude that the COOH-terminal portion 
of the tail is required for proper localization of Smylp. The 
truncation w~uld not be expected to inactivate the putative 
motor domain, so we looked for possible deleterious effects 
of overexpressing this construct in either wild-type (SLY87) 
or smylA (SLY86) cells, but did not observe any; truncated 
Smylp had no effect  on actin, Myo2p, or tubulin localization. 
Double Labeling of  Actin and Myo2p or Smylp 
To compare the localization of Myo2p, Smylp, and actin, we 
have  labeled  cells  (strain  SLY87  +  YEpSMY1-26)  with 
rhedamine-phalloidin and either anti-Myo2p or anti-Smylp 
antibody. Smylp and Myo2p are concentrated in the same 
Figure  3.  Immunolocalization of  Smylp. (a)  Wild-type cells 
(SLY87) labeled with anti-Smylp  antibody.  Labeling of  the mother- 
bud neck can be seen on the two large-budded cells at the bottom 
of the panel. (b) W'rid-type  cells carrying SMY/on a high-copy- 
number plasmid (SLY87 + YEpSMYI-26), labeled with anti-Smylp 
antibody. Arrows indicate unbudded cells  with  flat patches of 
Smylp, which are morphologically  distinct from the caps of Smylp 
seen elsewhere in the figure. The staining of ceils overexpressing 
SMY/is actually much brighter than is apparent in this figure; they 
were underexposed  relative to the cells in panel a to achieve  an opti- 
mum appearance. Bar, 5/tm. 
general regions of the cell as actin spots, at the same times 
during the cell cycle and during mating (Fig. 4). Cells with 
Myo2p or Smylp at the mother-bud neck also had actin 
clustered at the neck, confirming that the timing of  this local- 
ization was  similar.  Unbudded cells  with fiat patches  of 
Smylp or Myo2p also had in the same region large faint 
clusters of  actin that are characteristic of residual neck stain- 
ing (Haarer, B.K., unpublished results; Kim et al., cited in 
Ford and Pringle,  1991; Lew and Reed,  1993).  Unbudded 
cells with caps of Smylp or Myo2p also had in the same re- 
gion smaller brighter clusters of actin spots that are charac- 
teristic of incipient bud sites  (Haarer,  B.K., unpublished 
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rhodamine-phalloidin  (b). Arrows indicate a cell displaying both a cap and a fiat patch of Myo2p, with actin spots clustered in the same 
regions. Bar, 5 ~m. 
results;  Adams and Pringle,  1984;  Lew and Reed,  1993). 
These comparisons, which are most readily made in ceils 
having both a cap and a patch (see ceil indicated by the ar- 
rows in Fig. 4, a and b), constitute a second piece of  evidence 
that the cap marks the incipient bud site, whereas the patch 
marks the site of the previous mother-bud neck. 
Although  we  cannot  readily  do  Smylp/Myo2p  double 
labeling,  comparisons  to  the  actin  staining  indicate  that 
Myo2p and Smylp effectively coloealize; they are found in 
the same regions of the cell and their localization patterns 
are indistinguishable.  In contrast,  although aetin spots are 
also concentrated in the same general regions of the cell, 
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ceils, the Smylp/Myo2p caps or flat patches overlie clusters 
of actin spots, but do not appear to be made up of a cluster 
of spots themselves. In some ceils, the cluster of actin spots 
can be seen to form a ring; in this case, the Smylp/Myo2p 
cap or patch often lies within the ring (Fig. 4). In small buds, 
the Smylp/Myo2p cap often appears to lie in a region devoid 
of actin spots.  We looked for, but did not find any evidence 
that Smylp/Myo2p might be associated with actin cables. 
However, we cannot rule out such a localization, especially 
given the background glow. 
We have asked whether actin or Myo2p arrives first at the 
incipient bud site, as this might tell us something about the 
mechanism by which they localize. All unbudded cells with 
Myo2p (or Smylp) caps had a cluster of actin spots in the 
same region, but some cells with a cluster of actin spots had 
no detectable Myo2p or Smylp cap. It may be that actin ar- 
rives first, but due to the variability and fainter staining of 
Myo2p, we cannot rule out the possibility that Smylp and/or 
Myo2p arrives at about the same time. 
Mutants with Multiple Buds 
The temperature-sensitive mutants, cdc4 and cdcll,  both 
produce multiple elongate buds at restrictive temperature, 
with striking actin cables and polarized cortical spots in a 
subset of the buds (Adams and Pringle, 1984).  Using Con 
A pulse labeling, Adams and Pringle (1984) have demon- 
strated that only those buds containing polarized actin are 
actively growing, at the bud tips. Therefore, these cells are 
especially well suited to comparisons of actin and Smylp or 
Myo2p distributions, as we can ask which buds have Smylp 
or Myo2p caps. Double labeling of cdc4 (314D5)  or cdc11 
0PT194-HO1) cells after 4 or 6 h at restrictive temperature 
(36°C) all yielded identical results. We confirmed that actin 
was concentrated in a subset of the elongate buds, both as 
spots clustered at the tips, and as prominent cables (Fig. 5, 
b and d). This same subset of buds displayed Myo2p caps 
(Fig. 5 a) and (in experiments where staining was optimal) 
Smylp caps (Fig. 5 c). Conversely, no Myo2p or Smylp caps 
were detected at bud tips that lacked actin.  Interestingly, 
while the Smylp/Myo2p staining was brighter than the actin 
staining at a number of bud tips, the opposite was true for 
small projections, which we take to be new buds (data not 
shown). (Examples of such small projections can be seen in 
Fig. 5 e.) Since actin cables are more prominent in these mu- 
tants than in wild-type cells, we again looked for but were 
still unable to detect any obvious association of Myo2p or 
Smylp with the cables. 
In contrast to the distribution of Smylp, Myo2p, and actin 
(Fig. 5 f), staining of the cdc4 mutant for tubulin (Fig. 5 g) 
confirmed that virtually every bud contains a prominent bun- 
dle of  cytoplasmic microtubules (Adams and Pringle, 1984). 
By  extrapolation,  some  buds  have  microtubules  but  not 
Smylp or Myo2p caps. Thus, there is a correlation between 
Smylp/Myo2p localization, actin localiTation, and regions of 
cell growth in these mutants, but there is not a correlation 
between  buds  with  Smylp/Myo2p  caps  and  those  with 
microtubules. 
Temperature Shift 
Shifting wild-type cells from RT to 36°C (cells grow well at 
both temperatures) causes a  dramatic, although transient, 
rearrangement of  the actin cytoskeleton (Palmer et ai., 1992; 
Lew and Reed, 1993). We would like to understand as much 
as possible about the mechanics of this rearrangement, for 
two reasons. First, we would like to study the localization 
of Myo2p and Smylp in various temperature-sensitive mu- 
tants, and perturbation of actin upon temperature shift is a 
complicating factor. Second, we would like to look at what 
happens to Myo2p and Smylp localization in wild-type ceils 
when actin is perturbed (recognizing that temperature shift 
also has many other effects on the cell). 
Therefore, we have looked closely at the timing of several 
changes in the actin cytoskeleton upon temperature shift of 
wiM-type ceils (C276). The earliest event that we observed 
was a rapid but transient reduction in filamentous actin (Fig. 
6),  quantitated fluorometrically using extracts of cells la- 
beled  with  rhodamine-phalloidin  (Howard  and  Oresajo, 
1985).  The amount of filamentous actin decreased 25-50% 
within 30 s, and returned to initial levels within 3 min of the 
shift. Fluorescence microscopy of cells stained with rho- 
damine-phalloidin revealed that actin cables became fainter 
or disappeared at about the same rate as filamentous actin 
was lost. However,  the cables did not reappear as rapidly, 
taking 2 h or more to return to their original intensity. Ac- 
tin spots (which are also composed of filamentous actin) 
lost their localization to the bud or incipient bud site more 
slowly; maximal loss  of polarization was  seen at  1/2  h. 
Recovery of spot polarization appeared complete within 2 h. 
We also confirmed an earlier observation that there is a tran- 
sient increase in the frequency of unbudded cells upon tem- 
perature shift (Plesset et al., 1987); this was maximal at I h. 
Next,  we asked whether Myo2p or  Smylp localization 
were  also  affected by  temperature  shift.  Wild-type cells 
(SLY87) were shifted from RT to 36°C,  fixed at intervals 
from 5 rain to 2 1/2 h, and parallel aliquots were stained with 
antibody to Myo2p, Smylp, actin, or tubulin. (Mock-shifted 
cells  were  indistinguishable from untreated  ceils.)  Actin 
changes were as described above, except cables were detect- 
able longer (for 10 rain) and returned earlier (45 rain) after 
temperature shift (Fig. 7 a). This difference was not unex- 
pected, as we (and others; Adams and Pringle, 1991) have 
found that actin antibody is more sensitive in detecting ca- 
bles than is the rhodamine-phalloidin used in the previous 
experiments. As expected, the arrangement of microtubules 
was not grossly altered by temperature shift (Palmer et al., 
1992 have previously shown that although spindles become 
misoriented  upon  temperature  shift,  there  are  no  gross 
changes in microtubule morphology). 
We found that Myo2p localization was also perturbed by 
temperature shift (Fig. 7 b). Furthermore, Myo2p caps dis- 
appeared and reappeared with a time course similar to that 
of  actin spot depolarization and repolarization (compare Fig. 
7,  a  to b).  We noted that Myo2p caps were significantly 
brighter upon recovery from temperature shift (75 rain) than 
in mock-shifted or untreated cells (Fig. 7 b). In addition, 
medium to large buds often displayed several brightly stain- 
ing regions upon recovery, a pattern that was seldom seen in 
unperturbed ceils (although this same pattern was also seen 
in cells overexpressing SMY1; Fig. 8 c). In contrast, no in- 
crease in the intensity of actin staining was noted (although 
this staining was brighter to begin with). 
Examination of Smylp staining revealed that it, too, was 
sensitive to temperature shift (Fig. 7 c). Smylp caps, which 
were initially fainter than Myo2p caps, appeared to be lost 
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Figure 6. Effect of temperature shift on the amount of filamentous 
actin. Duplicate aliquots of wild-type cells (C276) were shifted to 
36°C (closed circles) or mock-shifted to RT (open squares). The 
amount of rhedamine-phalloidin that bound to cells fixed at various 
timepoints after temperature shift is expressed in arbitrary fluores- 
cence units. 
earlier. However, they recovered with a similar time course 
as Myo2p caps, and also appeared brighter upon recovery. 
Most likely Myo2p and Smylp respond identically to tem- 
perature shift, with the apparent differences being due to a 
detection problem with Smylp. The similarity to the time 
course of actin  rearrangement suggests  but by no means 
proves that Myo2p and Smylp localizations may both be de- 
pendent on actin. 
In contrast to the behavior of  Myo2p caps, Myo2p staining 
at mother-bud necks and in flat patches on unbudded cells 
was insensitive to temperature shift (Fig. 7 b). This observa- 
tion further supports the notion that the flat patches are left- 
overs from the neck staining of the previous cell cycle, and 
raises the interesting question of why staining in this region 
behaves differently. It was  difficult to determine whether 
Smylp necks and flat patches were also temperature-insen- 
sitive, as they were difficult to detect at RT or at early times 
after temperature shift. (They did stain brightly at 75 min 
and 2 h after temperature shift, the times at which Myo2p 
staining had also become brighter.) Therefore, we examined 
cells  overexpressing SMYI  (SLY87  +  YEpSMY1-26),  in 
which the  Smylp staining  should be more detectable.  In 
these cells, necks and flat patches stained as well for Smylp 
as  for Myo2p at  15  and 45  rain  after temperature shift, 
a) Actin  b)  Myo2p  c)  8mylp 
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Figure 7. Effects of temperature shift on Myo2p, Smylp, and actin 
localization. Wild-type cells (SLY87)  were shifted from RT to 36"C 
for various times, and stained with (a) anti-aetin antibody, (b) anti- 
Myo2 antibody, or (c) anti-Smylp antibody. Cells were scored for 
(a)  the presence  of actin cables or actin  spot polarization,  (b) 
Myo2p staining at caps  (on unbudded  or small-budded cells), 
necks, or fiat patches, and (c) staining of Smylp caps. Relative 
staining intensities of these structures (or degree of polarization of 
actin spots) at various times after temperature shift are represented 
qualitatively by pluses and  minuses;  note that these  intensities 
should  be  compared  only within  a  column,  and  not between 
columns. 
whereas Smylp/Myo2p caps were lost (at  15 min).  Thus, 
Smylp  staining,  like  Myo2p  staining,  at  necks  and  flat 
patches was stable to temperature shift. We also note that 
overexpressed Smylp does not prevent cap loss by stabilizing 
either Myo2p or Smylp. 
Actin Mutants 
To further explore the possible role of actin in Myo2p and 
Smylp localization, we looked at Myo2p, Smylp, and actin 
in  temperature-sensitive actin  mutants.  W'fld-type (DBY- 
2003), act/-/(DBY1999), and acd-2 (DBY2018) cells were 
examined at 20°C (permissive temperature) and after 75 min 
or 2 1/2 h at 36°C (times when wild-type cells have recovered 
from temperature shift, and the majority of  act/mutant cells 
are still viable; Novick and Botstein,  1985).  As expected 
(Novick and Botstein, 1985), actin spots were not polarized 
in most act/ceils, even at 20°C.  Furthermore, ceils were 
very heterogeneous in size, including many that were very 
large and round. We observed Myo2p caps in both actl mu- 
tants at 20°C, although at a much lower frequency than in 
wild-type cells. (These caps, when seen, were found in mor- 
phologically normal small buds.) At 36°C, caps were rare; 
Figure 5. Labeling of a multiply budded mutant. Mutant cdc4 cells (314D5) grown at restrictive temperature (36°C) were double labeled 
with anti-Myo2p antibody (a) and rhodamine-phalloidin (b); with anti-Smylp antibody (c) and rhodamine-phalloidin (d); or single labeled 
with anti-Smylp antibody (e); anti-actin antibody (f); or anti-mbulin antibody (g). The actin staining was less intense in double-labeling 
experiments (b and d) than it was in single-labeling experiments using either anti-actin antibody (f) or rhodamine-phalloidin, making it 
more difficult to record the actin staining photographically. For example, we could observe actin as well as Myo2p staining at the neck 
of the cell shown at the bottom of a and b. Bar, 5/~m. 
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pression. W'tld-type  cells (SLY87)  plus control vector (+ YEp352, 
a) or plus SMY/on a high-copy-number  plasmid (+ YEpSMY1-26, 
b) were labeled with anti-Myo2p antibody, and printed at the same 
exposure so that relative intensity of staining can be compared, c 
shows the staining of medium-sized buds,  which becomes more 
pronounced in cells overexpressing SMY/. Bar, 5 t~m. 
the loss was greater in the actl-1 than the act1-2 mutant. We 
saw no indication that Myo2p localized to the abnormal actin 
"bars"  present  in  act1-2 mutants  (Novick  and  Botstein, 
1985). Similar results were obtained for Smylp. Thus, muta- 
tions in actin interfere directly or indirectly with Myo2p and 
Smylp localization. We hypothesize that the occasional cell 
at 36°C which has a normal small bud and Smylp/Myo2p 
cap may be due to residual actin function. (It seems likely 
that mutant actin can have residual function in the absence 
of detectable localization, as the mutants bud and grow rela- 
tively normally at permissive temperature even though actin 
localization appears disrupted; Novick and Botstein, 1985.) 
Effects of  SMY1 Dose on Myo2p Localization in 
Vdld-l~ype and myo2 Mutant Cells 
The colocalization of Smylp and Myo2p suggested that they 
might in some way be interdependent. Therefore, we have 
examined the effects of SMY1 deletion and overexpression on 
Myo2p localization. Interestingly, overexpression of SMY1 
in wild-type cells (SLY87 +  YEpSMY1-26) increased the in- 
tensity of not only the Smylp cap (see above), but also the 
Myo2p cap, as compared to the wild-type control (SLY87 + 
control vector) (compare Fig. 8, a  and b). Although SMY1 
overexpression enhances  Myo2p  localization,  it  did  not 
stabilize Myo2p caps against the effects of temperature shift 
described above. Deletion of SMY1, on the other hand, had 
little effect; Myo2p caps appeared normal or perhaps slightly 
fainter in a smylA strain (SLY86), both at 200C and after 
recovery from temperature shift. We conclude that Smylp 
can enhance but is not required for Myo2p localization in 
wild-type MY02 cells. 
Given these results, it was clearly of  interest to ask ifSMY1 
overexpression also enhances localization of mutant Myo2p, 
as  this  could tell  us  something about the mechanism for 
SMY1 suppression of the myo2 mutant defects. First, we ex- 
amined Myo2p localization in temperature-sensitive myo2 
strains (SLY34, SLY88, SLYgl, 5: control vector). At 200C 
(Fig. 9 a), a temperature at which these mutants grow well, 
Myo2p localization was reduced significantly as compared 
to that of either wild-type strains (SLY54, SLY87) or a myo2 
mutant  with  plasmid-borne  wild-type  MY02  (SLY88  + 
YCpMYO2). After shifting cells to 30, 32, or 36°C, Myo2p 
localization disappeared as expected in response to the tem- 
perature shift, but did not recover in the myo2 mutant (after 
75 min, 4 3/4 h, 6 h, 12 h, or 18 h) (Fig. 9, b and c), in con- 
trast to wild-type cells or myo2 cells carrying YCpMYO2. 
Strikingly, SMY1 overexpression, which suppresses the tem- 
perature sensitivity of the myo2 mutant at 30 or 320C (Lillie 
and Brown, 1992), also restored the ability of Myo2p to re- 
cover its localization. That is, myo2 mutants carrying SMY1 
on  a  high-copy-number  plasmid  (SLY34  or  SLY88,  + 
YEpSMY1-26)  localized Myo2p at about wild-type levels 
both at 20°C (Fig. 9 d), and at times after shift to 30 or 32°C 
(75 min, 4  3/4 h, 6 h,  12 h,  18 h) (Fig. 9,  e and f) when 
wild-type cells (SLY87 +  control vector) had recovered, but 
myo2  mutants  with  control  vector had  failed  to  recover 
Myo2p localization (Fig. 9, b and c). Thus, overexpression 
of Smylp may suppress the myo2 defect by participating ei- 
ther in delivery of Myo2p, or in maintenance of its local- 
ization. In contrast, overexpression of SMY2 (a second mul- 
ti-copy suppressor of myo2; Lillie and Brown,  1992;  see 
Introduction) did not restore detectable Myo2p localization 
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ture sensitivity nearly as well as does SMY1. 
While it would be interesting to know whether overexpres- 
sion of Myo2p can enhance Smylp localization, such experi- 
ments are hard to interpret because of the deleterious effects 
of Myo2p overexpression (I-Iaarer et al.,  1994).  More in- 
formative was our examination of the effects of  the myo2 mu- 
tation on Smylp localization. Smylp caps appeared to be 
slightly fainter in the myo2 mutant than in wild type at RT. 
Furthermore,  upon temperature shift,  Smylp localization 
showed the same behavior as did Myo2p localization. That 
is, the myo2 mutant (SLY88  +  control vector) failed to re- 
cover Smylp localization after shift to 320C  (for 75  min, 
4 3/4 h, or 12 h). We conclude not only that Smylp plays a 
role in localization of Myo2p, but also that Myo2p plays a 
role in localization of Smylp. 
Secretory Mutants 
We have examined the localization of Myo2p and Smylp in 
temperature-sensitive  see1-1 (NY3  x  NY4)  and  sec6-4 
(NY16  ×  NY17) mutants. These mutants are blocked at a 
late stage in secretion, and accumulate secretory vesicles in 
the bud within 15  min of shift to restrictive temperature 
(Govindan et al., 1994). We reasoned that if Myo2p were as- 
sociated with secretory vesicles, as proposed by Johnston et 
al. (1991), we might see an increase in the intensity of  Myo2p 
staining in these mutants. However,  this was not the case. 
What we observed instead was a permanent loss of actin, 
Myo2p, and Smylp localizations upon  shift to restrictive 
temperature. Although these localizations were all normal in 
the mutants at RT, and were lost as expected upon shift to 
360C, neither mutant strain recovered from the temperature 
shift; after 75 min and 2 h at 36°C, actin spots remained un- 
polarized and no Myo2p or Smylp caps were found. We also 
looked carefully at earlier timepoints (15, 30, and 50 rain) for 
any indication of Myo2p or Smylp accumulation, but found 
none. Similar results were obtained with the sec7-1 mutant 
(NY757  ×  NY760), which is blocked at an earlier stage of 
secretion (Schekman, 1992). We conclude that mutations in 
these secretory genes interfere directly or indirectly with ac- 
tin, Myo2p, and Smylp localizations. The fact that an (puta- 
five) increase in secretory vesicles at the bud tip in see1 or 
sec6 mutants does not result in an increase in Smylp/Myo2p 
cap  intensity indicates either that the mutations interfere 
with a hypothetical association between Smylp/Myo2p and 
the secretory vesicle, or that cap staining does not in fact cor- 
respond to groups of secretory vesicles at the bud tip. 
Osmotic Stress 
Chowdhury et al. (1992) have shown that osmotic stress in- 
duces the same dramatic and transient changes in the actin 
cytoskeleton that are observed upon temperature shift. We 
examined the effects of osmotic stress on Myo2p and Smylp 
localization for two reasons. First, it was of interest to know 
whether altering actin localization using a  different stress 
would have the same effects on Myo2p and Smylp. Second, 
we wanted to know whether the myo2 mutant, like strains 
with actin defects (Chowdhury et al., 1992), might be osmo- 
sensitive as well as temperature-sensitive. We examined ac- 
tin, Myo2p, and Smylp localizations after addition of 0.4 M 
NaC1 to wild-type (SLY87), smylA (SLY86), and myo2 mu- 
tant (SLY88) strains growing at 20°C. Rearrangements ofac- 
tin, Myo2p, and Smylp in wild-type cells occurred with the 
same time course as during temperature shift: at 5 min after 
addition of salt there were no detectable changes, but by 30 
rain actin cables had disappeared, actin spot polarization was 
lost, and Smylp/Myo2p caps had disappeared. By 2 h the 
original localizations were restored and Smylp/Myo2p stain- 
ing was brighter than before the shift, as observed upon tem- 
perature shift. Mock-treated cells of each strain were indis- 
tinguishable from untreated cells. Thus, osmotic stress, like 
temperature shift, promotes changes in Myo2p and Smylp 
localization that show a temporal correlation with changes 
in actin arrangement. Cells lacking Smylp behaved similarly 
to wild type, except, of course, for the fact that Smylp was 
absent. The myo2 mutant strain also behaved similarly to 
wild type, except for the fact that Myo2p (and possibly Smylp) 
staining was less intense throughout. The fact that myo2 cells 
recovered from osmotic shift but not temperature shift sug- 
gests that the defect is not an inability to reform caps after 
any stress-induced delocalization. The rayo2 mutant strain 
gave no other indication of being osmosensitive; salt did not 
affect the growth rate or the wild-type morphology of cells 
followed for ~ten generations +  0.4 M NaCl at 20°C. As 
a  control, we confirmed that a parallel aliquot of cells at 
30°C  developed  the  morphology  expected  at  restrictive 
temperature. 
Overexpression  of  SMYI Did Not Rescue a MY02 
Deletion Strain 
To learn whether Smylp can bypass the need for Myo2p, we 
asked whether SMY1 overexpression could rescue a MY02 
deletion (myo2A) strain, as it does the myo2 mutant. John- 
ston et al. (1991) have shown that disruption of MY02 is le- 
thal. However, since we have found that the portion of  MY02 
that remains intact in that disruption gives deleterious results 
when introduced into yeast on a high-copy-number plasmid 
(Haarer et al., 1994), we have constructed a more complete 
deletion. We deleted one copy of the gene in a diploid strain 
by a  one-step  gene  replacement that left only the  NH2- 
terminal  83  and  COOH-terminal  116  codons  of MY02 
marked with the TRP1 gene (Fig. 10 c). Southern blot analy- 
sis confirmed that the expected gene replacement had oc- 
curred in the MYO2/myo2A::TRP1 diploid SLY107 (data not 
shown). Tetrad analysis confirmed that myo2A::TRP1 segre- 
gants are  unable to grow.  Of 12  tetrads,  10  gave 2  live 
(Trp-):  2 dead segregants and 2 tetrads gave  1 live (Trp-): 
3 dead segregants; most of the "dead" segregants germinated 
and produced two to four cells. When plasmids were intro- 
duced into SLY107, subsequent tetrad analysis showed that 
MY02 on a low-copy-number plasmid (YCpMYO2) rescued 
myo2A  segregants as expected.  However,  SMYI  on high- 
copy-number plasmid YEpSMY1-38 (like control vector) did 
not rescue myo2A segregants: of 31 tetrads, 29 gave 2 live 
(Trp-):  2 dead segregants and the other 2 gave 1 live (Trp-): 
3 dead segregants. These dead segregants, like those above, 
germinated but failed to produce more than two to four cells. 
While we cannot demonstrate directly that the dead myo2A 
segregants retained YEpSMY1-38, it seems likely that many 
did, since both live segregants of 17 tetrads retained plas- 
mid.  We also found that myo2A segregants carrying both 
YCpMYO2 and YEpSMY1-38 were unable to lose YCpMYO2 
even after long periods of growth in medium selecting only 
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Figure 10. Physical  map of  the MY02 region and constructs derived 
from it. (a) Restriction map of  the MYO2-containing insert plus ad- 
jacent vector sequence of YCpMYO2. The box indicates the posi- 
tion of  the MY02 open reading frame, which encodes the head (sttp- 
pied), neck (vertical  stripes), and tail (diagonal stripes) of Myo2p. 
(b)  The fragment of MY02 incorporated into gene fusions for 
production of anti-Myo2p antibodies. (c) The construct used in 
makin~ the MY02 deletion (insert of plasmid pAM::TRPI). (d) 
The insert of the gap-repair plasmid, YCpMYO2-12, used to re- 
cover the fragment containing the myo2-66 mutation, shown in e. 
(e) The fragment containing the myo2-66  mutation, which was se- 
quenced. (f) The amino-acid sequence alteration  caused by the 
myo2-66  mutation.  Thick  lines  represent  yeast  sequences;  thin  lines 
represent  vector  sequences. Not all Bgi If, Eco RV, HI  m I, and 
Sau3A sites  are shown. 
for YEpSMY1-38  (,~30 generations). (Most wild-type seg- 
regants have lost YCpMYO2 under these conditions.) Thus, 
overexpression of SMY/cannot rescue myo2A spores, and al- 
most certainly cannot replace MY02 in vegetatively grow- 
ing cells. 
Mapping and Sequencing the myo2 Mutation 
Since Myo2p has several functional domains, deduced from 
comparisons to other myosins (Cheney et al., 1993),  deter- 
mining where the defect lies in mutant Myo2p might suggest 
how  it is  malfunctioning. Using  recomb'mation-mediated 
marker rescue, we determined that the mutation responsible 
for temperature sensitivity of  the mutant (allele myo2-66) lay 
within a 1-kbp Xba I fragment (Fig. 10 e). This segment was 
recovered by "gap repair" (Rothstein, 1991) from two differ- 
ent strains (SLY1, SLY33) carrying the myo2 mutation. Both 
DNA segments, as well as the corresponding wild-type seg- 
ment from plasmid YCpMYO2,  were sequenced and the 
only change (in both mutant DN/fs) was a G to A transition 
at the third position of the codon for Glu511,  altering it to 
a  Lys (Fig.  10 f).  While the  marker-rescue  experiment 
showed that this mutation is necessary for temperature sensi- 
tivity, it does not rule out the possibility that there are muta- 
tion(s) in other regions of myo2 that are also required. We 
addressed this point using the low-copy-number plasmids 
generated by gap repair, which contain the above Xba I seg- 
ment of  either myo2 or MY02 in an otherwise wild-type copy 
of the gene. These gap repair plasmids were introduced into 
a MYO2/myo2A  diploid (SLY107) and tetrad analysis was 
carried out. As expected, the control plasmid carrying the 
MY02 segment rescued myo2A segregants not only at RT, 
i  but also at 36"C, and the cells displayed wild-type morphol- 
ogy. The plasmids carrying the myo2 segment also rescued 
myo2A segregants at RT, but at >300C these segregants ar- 
rested with characteristic myo2 mutant morphology. Thus, 
it seems likely that the single mutation is both necessary and 
sufficient for the temperature sensitivity of the myo2 mutant. 
Rayment et al. (1993) have recently published the crystal 
structure of the motor domain of a chicken skeletal myosin. 
We can unambiguously align Glu511 in Myo2p with Glu527 
in the chicken myosin, a residue at the actin binding face of 
the "lower 50K domain7 Glu527 forms a salt bridge with Lys 
486 (Payment, I., University of Wisconsin, personal com- 
munication), a residue that can be unambiguously aligned 
with Lys471 in Myo2p. Thus, the alteration of Glu511 to a 
Lys is likely to perturb the actin binding of Myo2p. 
Discussion 
Myo2p and Smylp Colocalize to Regions 
of  Polarized Growth 
Our  finding that overexpression of Smylp can  overcome 
defects in the myo2 mutant (Lillie and Brown, 1992) raises 
the question of how a protein with sequence similarity to 
kinesin can partially compensate for a defect in a myosin. Be- 
cause this finding is so unexpected, we originally suspected 
that the mechanism might be rather indirect. However,  im- 
munolocalization results strongly argue for a direct relation- 
ship between Smylp and Myo2p, as these proteins appear to 
colocalize under all conditions examined. They show the 
same re.arrangements  during the vegetative cell cycle and in 
response tomating. They also show the same response to ei- 
ther temperature or osmotic shift; caps of Smylp and Myo2p 
are perturbed and recover with the same time course, while 
neck and flat-patch staining of both are unperturbed. Muta- 
tions in actin or secretory genes have the same effect on 
Smylp and Myo2p. Furthermore, overexpression of Smylp 
enhances Myo2p localization in wild-type cells, and restores 
Myo2p localization in the myo2 mutant at restrictive temper- 
ature. These findings suggest that Smylp and Myo2p may be 
physically associated, although we know little about the na- 
ture of the association. Smylp may bind directly to Myo2p, 
or be indirectly associated in a  supramolecular complex. 
Perhaps SMYI overexpression suppresses the myo2 mutation 
but not MY02 deletion because Smylp is binding to and 
Figure 9. Myo2p localization in the myo2  mutant. Mutant cells (SLY88) carrying (a-c) control vector (YEp352) or (d-f) SMY1 on a high- 
copy-number plasmid CYEpSMY1-26) were incubated at 20°C (a and d) or at 32°C for 75 rain (b and e) or 4 3/4 (c and f), and labeled 
with anti-Myo2p antibody. Exposure times of all panels were matched so that the intensity of staining can be compared. The cells shown 
in the montage in a were chosen to show the range of staining intensities seen at permissive temperature. After  4 3/4 h at restrictive tempera- 
ture, the increase in cell size originally reported by Johnston et al. (1991) is obvious (c), and is suppressed by SMY/overexpression (f). 
Although buds are rare on myo2 mutant cells at this time point, we have shown an example in c (arrow), in order to make the point that 
Myo2p staining is not seen in these buds. Bar, 5/zm. 
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to invoke direct binding of Smylp to Myo2p to explain the 
suppression results. An alternative explanation is that MY02 
deletion causes a more severe defect than the myo2 mutation, 
so that more Smylp function is needed to compensate. This 
fits with our observations that no Smylp is required when 
wild-type  Myo2p is present  (in smylA strains),  the normal 
level  of  Smylp is  required  to  compensate for  the  defect  in  mu- 
tant  Myo2p at  room temperature (as  smylA  myo2  double mu- 
tants  are inviable;  Lillie  and Brown, 1992),  ovcrexpression 
of  Smylp is  required  at  30-32°C when there  may be a more 
severe  defect  in  mutant Myo2p, and even ovcrcxpression  of 
Smylp is insufficient  at 36°C (or at any temperature when 
MY02 is deleted). 
We conclude not only that Smylp and Myo2p are likely to 
be associated, but also that they probably participate in the 
same function of polarized growth. This conclusion is based 
on the phenotype of the myo2 mutant (Johnston et al., 1991 
and see Introduction), its partial suppression by overexpres- 
sion of  SMY/(Lillie and Brown, 1992), and immunolocaiiza- 
tion of both Smylp and Myo2p to sites of polarized growth. 
Similar localizations have been seen for Bemlp, Spa2p,  and 
Cdc42p,  all of which are also implicated in this process. 
Bemlp has been implicated in bud site assembly (Chant et 
al., 1991; Chenevert et al.,  1992),  and its immunolocaliza- 
tion pattern (Corrado, K., University of Texas, and J. Pringle, 
University of North Carolina, personal communication) is 
very similar to that of Smylp/Myo2p. Cdc42p is a Rho-like 
GTPase which participates in a  step of bud-site assembly 
that is upstream of actin (Johnson and Pringle, 1990; Ziman 
et al., 1991). It immunolocalizes to the same regions of the 
cell as Myo2p (Ziman et al.,  1993).  Spa2p,  on the other 
hand, is not required for bud formation and growth, but does 
appear to be involved in the polarized growth that occurs in 
mating cells (Gehrung and Snyder,  1990).  The published 
Spa2p localization (Snyder et al., 1991) differs from Smylp/ 
Myo2p localization in that Spa2p persists as a cap in medium 
and large buds. However, Spa2p is concentrated in all of the 
same regions as Smylp/Myo2p, and many aspects of its be- 
havior are similar; it is found only in the subset of buds that 
contain clusters of actin in multiply budded mutants, and it 
is not completely delocalized in act1-1 and act1-2 mutants 
(Snyder et al., 1991). Another protein with a similar local- 
ization pattern (Novick and Brennwald,  1993) is Sec4p, a 
Rab GTPase implicated in fusion of secretory vesicles with 
the plasma membrane. Finally, calmodulin localization is in- 
.distinguishable from that of Myo2p/Smylp, presumably be- 
cause calmodulin binds to Myo2p (Brockerhoffet al., 1994). 
Alteration of  Smylp and Myo2p Domains 
We investigated which domains of Smylp and Myo2p might 
be  required  for  localization.  Both  of these  proteins  are 
predicted to have the organization typical of motor proteins, 
including a  head with putative motor activity, and a  tail 
which may attach to a "cargoY Truncation of Smylp indicates 
that the COOH-terminal portion of the tail is required for lo- 
calization (in a smylA background), and for suppression of 
the growth defect of the myo2 mutant. We do not know cur- 
rently whether the head of Smylp is also required. (We do 
know that overexpression of truncated Smylp, which pre- 
sumably still has an active head, does not interfere with wild- 
type Myo2p localization.) In the case of Myo2p, mapping of 
the myo2 mutation to the head, together with the observation 
that mutant Myo2p does not localize well, suggests that the 
head is involved in localization. It is more difficult to assess 
whether the tail is also required, because we can examine the 
behavior only of functional Myo2p's in the (lethal) MY02 de- 
letion strain. However, Myo2p caps do appear brighter when 
a truncated Myo2p is overexpressed in otherwise wild-type 
cells (unpublished observations). Thus, either (part of) the 
tail is not required for localization, or wild-type Myo2p can 
help localize the truncated Myo2p, perhaps by dimerization. 
The Role of  Actin Filaments and Microtubules 
Since the sequences of Smylp and Myo2p suggest that they 
could be motor proteins that move along microtubules and 
actin, respectively, an important question is what role these 
filaments play in Smylp and Myo2p function. Several pieces 
of evidence implicate actin but not microtubules. First, the 
myo2 mutation is predicted to alter an actin contact site, 
based on the structure of chick myosin (Rayment et al., 
1993). Second, the similarity in the phenotypes of actin and 
myo2 mutants (Johnston et al., 1991) indicates that Myo2p, 
like actin, functions in polarized cell growth. In contrast, 
microtubules are not normally required for polarized growth 
(see  Introduction).  Third,  actin,  Smylp,  and  Myo2p  all 
localize to regions of polarized growth,  and undergo the 
same rearrangements at each stage in the cell cycle. Lew and 
Reed (1993) present evidence that actin rearrangements are 
under the control of cell-cycle-specific cyclins. G1  cyclins 
appear to be involved in bud initiation, triggering the assem- 
bly  of a  cluster  of actin  spots  at the  incipient bud  site. 
Smylp/Myo2p arrive at the incipient bud site either simul- 
taneously with or immediately after actin. Early on, buds 
grow at their tips,  but later on are induced to switch to 
isotropic growth by a  subset of G2 cyclins. Smylp/Myo2p 
caps are localized at the growing tips of small buds, but can 
not be visualized in older buds; perhaps discrete caps disap- 
pear coincident with the switch to isotropic growth. A failure 
to make this switch can result in elongate buds, similar to 
those seen in multiply budded mutants. The fact that a num- 
ber of the buds in such mutants retain Smylp/Myo2p caps, 
even though the buds are much larger than normal, argues 
that the normal loss of caps is not simply due to dilution dur- 
ing bud growth, but may instead result from the switch. Later 
in the cycle, inactivation of the cyclin-kinase complex ap- 
pears to be responsible for the rearrangement of actin to the 
mother-bud neck. Smylp and Myo2p are also concentrated 
at the neck at this time. Actin persists at the neck for a while 
after completion of cell separation or septation, as a large 
faint cluster of actin at the site of the former neck sometimes 
can be seen in unbudded cells (Kim et al., cited in Ford and 
Pringle, 1991; Lew and Reed, 1993).  Smylp/Myo2p appear 
to persist in like manner, as fiat patches associated with the 
clusters of actin. 
Actin and  Smylp/Myo2p behave  similarly under other 
conditions. First, in the multiply budded cdc4 mutant, only 
the subset of  buds that have a concentration of  actin spots and 
prominent cables also have Smylp/Myo2p caps. Second, al- 
though many changes occur upon temperature or osmotic 
shift, there is a  striking temporal correlation between the 
dramatic rearrangements of actin spots and those of Smylp/ 
Myo2p in both situations. Finally, all three are affected in ac- 
tin and secretory mutants. In contrast, microtubules are not 
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spindles are transiently disoriented upon temperature shift; 
Palmer et al.,  1992).  The subset of buds in a  cdc4 cell 
that have microtubules but lack concentrations of actin also 
lack Smylp/Myo2p caps. Furthermore, using the cdc4 mu- 
tant,  we have observed that nocodazole does not abolish 
Smylp/Myo2p caps, during a period of hours after microtu- 
bules have disappeared  (Lillie,  S.  H.,  and S.  S.  Brown, 
manuscript in preparation). We conclude that while Myo2p 
is likely to interact with actin, there is no evidence to date 
that Smylp interacts with microtubules. Instead, there is evi- 
dence that Smylp interacts with Myo2p and/or actin in some 
way. Since neither microtubules (Jacobs et al., 1988; Huffa- 
ker et al., 1988) nor Smylp (Lillie and Brown, 1992) are re- 
quired for polarized growth in wild-type cells, but Smylp is 
required in the myo2 mutant, it will be interesting to deter- 
mine whether microtubules are also required in the mutant. 
Temperature and Osmotic Shift 
The earliest change we have detected upon temperature shift 
is a reduction in polymerized actin. Actin cables seem to be 
affected first, followed  by concomitant effects on the arrange- 
ment of Myo2p, Smylp, and actin spots.  Possibly,  actin ca- 
bles  might cause/direct Myo2p/Smylp localization. There 
are several aspects of the response to temperature shift that 
are unexplained. We do not know why actin depolymerizes, 
but suspect that depolymerization is not specific to tempera- 
ture shift and may occur in response to other stresses that 
result in actin rearrangement (see below). We do not know 
why it takes so much longer to restore the proper actin, 
Myo2p, and Smylp localization than it takes for the actin to 
repolymerize. Perhaps actin can only reorganize properly at 
certain times during the cell cycle (see the discussion of the 
cell-cycle control of actin by different cyclins, above).  We 
also do not know why the Myo2p/Smylp staining at the 
mother-bud neck is resistant to temperature shift (Fig. 7). 
Perhaps it is again a matter of different cell cycle controls. 
The effects of temperature shift can confound interpreta- 
tion of the phenotype of a temperature-sensitive mutant. For 
example, in the first hour after shift to restrictive tempera- 
ture, the loss in actin and Smylp/Myo2p organization is su- 
perimposed on the effects of the mutation. Failure to recover 
this organization at later times (e.g., by myo2 and secretory 
mutants) is hard to interpret. Even though these mutants do 
not show a large loss of viability in an hour, they nonetheless 
may be too sick to reorganize their actin properly. Alterna- 
tively, we may be seeing a direct effect of myo2 or secretory 
mutations on actin. Perhaps Myo2p participates in actin or- 
ganization (by anchoring it to  the bud tip?),  or perhaps 
Myo2p and secretory vesicles are  needed to  replenish  a 
polarized distribution of membrane components that orga- 
nize actin. 
Other perturbations may also complicate interpretation of 
phenotype. Rearrangements in actin have been documented 
not only upon temperature shift (Palmer et al.,  1992;  Lew 
and Reed, 1993),  but also in response to a variety of other 
stresses. Chowdhury et al. (1992) have demonstrated that os- 
motic shock gives rise to the same changes that are seen with 
temperature. Novick et al. (1989) found that cycloheximide, 
azide, or removal of glucose could also cause a loss of actin 
polarity. The stresses can be subtle; Pringle et al. (1989) have 
observed better preservation of actin polarity when fixative 
is added directly to cells shaking in medium than when cells 
are  first washed.  Thus,  actin rearrangement is easily in- 
duced, and may be a somewhat nonspecific mutant pheno- 
type that can be caused by a variety of metabolic or other 
changes in the cell.  For this reason,  actin rearrangement 
should be interpreted with caution. 
Given these caveats, we wondered about the specificity of 
the myo2 mutant phenotype. The actin mutants, act1-1 and 
act1-2, cannot recover from either temperature or osmotic 
shift (Novick and Botstein, 1985; Chowdhury et al., 1992), 
and may simply be incapable of recovering from any stress- 
induced loss of actin polarity. In contrast, we find that the 
myo2 mutant can recover from osmotic (although not tem- 
perature)  shift.  Two interpretations of this specificity are 
possible. Either the mutant Myo2p molecule is itself  temper- 
ature sensitive but not osmotically sensitive, or "dosage" (the 
reduction in Myo2p function) is more crucial at elevated 
temperature than at high osmolarity. Dosage is a plausible 
explanation for the osmosensitivity of actin mutants, as a 
diploid lacking one of its copies of the wild-type actin gene 
(ACT1/actlA) is also osmosensitive (see reference to Shortle 
in Chowdhury et al.  [1992]).  However,  as a MYO2/myo2A 
diploid is not thermosensitive (Johnston et al.,  1991), this 
level of Myo2p reduction is not sufficient to cause tempera- 
ture sensitivity, and the dosage hypothesis may not obtain. 
Possible Interpretations 
How might Smylp and Myo2p function in polarized growth 
and secretion? Myo2p appears to be required for delivery of 
vesicles to the bud. If vesicle fusion with the plasma mem- 
brane is blocked (in sed or sec6 mutants), vesicles build up 
in the bud; however, they build up in the mother cell of the 
myo2 mutant or of double mutants (Govindan et al., 1994). 
Perhaps Myo2p is a  secretory vesicle motor, as originally 
proposed by Johnston et al. (1991) based on their character- 
ization of the myo2 mutant. In this case, Smylp might en- 
hance Myo2p localization either by acting as a second vesicle 
motor or by somehow enhancing Myo2p activity. Another 
possibility is that Smylp/Myo2p are part of a complex of  pro- 
teins (perhaps including Bemlp, Cdc42p, and/or Spa2p) that 
sit at the incipient bud site and are involved in bud site assem- 
bly and/or bud growth. If this is the case, we speculate that 
Myo2p may anchor actin filaments, which may in turn act 
as railroad tracks for the polarized delivery of vesicles to the 
bud. In an attempt to distinguish between these possibilities, 
we asked whether Smyl/Myo2p staining in the bud increased 
in secl or sec6 mutants when vesicles reportedly build up. 
Since the staining did not increase (and in fact was lost under 
these conditions), we suspect that Smylp/Myo2p caps do not 
correspond to accumulations of vesicles at the site of fusion 
in the bud tip. However,  we cannot rule out the possibility 
that these mutations somehow interfere with the hypothetical 
binding of  Smylp/Myo2p to vesicles. An alternative possibil- 
ity is that Smylp/Myo2p are not abundant enough on vesicles 
to be  visualized, but become concentrated at the plasma 
membrane at the site where the vesicles fuse. 
A puzzling aspect of the myo2 mutant phenotype is that al- 
though vesicles build up in the mutant, several labs have 
been unable to demonstrate any dramatic build-up of secre- 
tory product within the cell (Govindan et al., 1994; Liu and 
Bretscher, 1992).  Based on studies of a-factor receptor, the 
explanation may be that Myo2p functions in recycling vesi- 
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dan et ell.,  1994). 
Although it seems likely that Myo2p is an actin-based mo- 
tor, we have not yet tested Myo2p for motor activity in in 
vitro motility assays.  Furthermore, there is no evidence that 
Smylp is a microtubule-based motor.  To the contrary,  our 
results  suggest that microtubules may  not be required  for 
Smylp localiTation,  at least in cells that are wild type for 
MY02. It will be interesting to ask whether microtubules are 
required under conditions where Smylp function is required, 
that is, in the myo2 mutant. 
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